ESC 365 - Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: experiences from the RELY trial

ESC Premium Access

Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: experiences from the RELY trial

Session: Best Posters Session 1 - Best Posters in the ongoing challenge to find the "perfect" biomarkers.

Topic: Biomarkers

Speaker: Associate Professor Z. Hijazi (Uppsala, SE)

Event: ESC Congress 2016

Congress Presentation

About the speaker

Associate Professor Ziad Hijazi

Uppsala University, Uppsala (Sweden)

4 presentations

0 follower

4 more presentations in this session

Discussant: Best Posters in the ongoing challenge to find the "perfect" biomarkers.

Predictive value of low testosterone concentrations regarding coronary heart disease and mortality in men and women: evidence from the FINRISK study

Speaker: Doctor M. Karakas (Hamburg, DE)

Troponin I and cardiovascular risk prediction in the general population

Speaker: Miss N. Makarova (Hamburg, DE)

Cyr61, a novel biomarker of acute coronary thrombotic occlusion improves risk stratification beyond the GRACE score when combined in a multimarker approach in patients with acute coronary syndromes

Speaker: Doctor R. Klingenberg (Bad Nauheim, DE)

Access the full session

Best Posters Session 1 - Best Posters in the ongoing challenge to find the "perfect" biomarkers.

Speakers: Associate Professor Z. Hijazi, Doctor M. Karakas, Miss N. Makarova, Doctor R. Klingenberg

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by